PATENT CLAIM ANALYSIS

Application Number: 15777009
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides a multi-peptide composition with antibacterial activity comprising at least 3 peptides with the sequences as set forth in SEQ ID NO:1, 2 or 3 (or related sequences), respectively, in which the SEQ ID NO:1 sequence (or its related sequence) comprises at least two tryptophan residues. In particular the invention provides a new bacteriocin, Garvicin KS. The invention also provides compositions and host cells containing such antibacterial compositions. Uses of the antibacterial composition in treating bacterial infection and products treated with the antibacterial composition are also provided.

Claim (Index 33):
An in vitro method of killing, damaging or preventing the replication of bacteria comprising administering a composition or host cell (preferably microorganism) as defined in any one of  claims 1  to  13  or  16  to  19  to said bacteria.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 93.0
- Lexical Diversity: 1.67213
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10296723', '13516534', '14278423', '12745299', '11129337']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6965353536449952
- 35 USC 102 Novelty (BERT): 0.5133689128742797
- Combined Prediction Score: 0.6782187095679237
- Mean Citation Score: 259.020846
- Max Citation Score: 267.97522000000004
- Similarity Product: 185.1474411740649

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test